Last updated: June 5, 2026
Back to directoryAI-enabled pathology viewers, algorithms, and diagnostic support for whole-slide images and lab workflows.
| Regulatory / FDA | Check diagnostic, research-use-only, CE-IVD, FDA, UK MHRA, or local status for each algorithm and tissue workflow. |
|---|---|
| Privacy | Review slide image storage, cloud processing, de-identification, LIS links, retention, and data-use terms. |
| Evidence | Require scanner-specific validation, tissue-type performance, lab population testing, pathologist review, and quality-control evidence. |
| Workflow | Map scanner, image management, LIS, reporting, pathologist signout, and exception handling before diagnostic use. |
| Product | Best fit | First verification check | Official sources |
|---|---|---|---|
| Paige | Pathology teams evaluating AI support for prostate biopsy review and digital pathology workflows. | FDA authorization and exact intended use for the selected product. | 2 official sources |
| PathAI | Labs that need an image management system with AI application access and pathology workflow support. | Which AISight version and algorithms are diagnostic versus research use only. | 4 official sources |
| Hologic Genius Digital Diagnostics | Labs modernizing cervical cancer screening workflows where ThinPrep slide handling, AI gallery review, and cytology quality controls can be validated together. | Whether the exact Genius Digital Diagnostics System, Genius Cervical AI algorithm, imager, server, and review station match the cleared intended use. | 5 official sources |
| Ibex Medical Analytics | Labs evaluating AI-assisted cancer pathology workflows across breast, prostate, gastric, or biomarker use cases. | Which Ibex module, tissue type, and workflow is being evaluated. | 6 official sources |
| Deep Bio DeepDx Prostate | Labs evaluating prostate core needle biopsy AI where pathologists can validate slide quality, review overlays, edit findings, and govern reporting responsibility. | Exact DeepDx Prostate module, specimen type, scanner, viewer, geography, CE or MFDS status, and whether the U.S. workflow is research-use-only. | 4 official sources |
| Proscia | Organizations building an enterprise digital pathology foundation that can connect image management, AI apps, and data workflows. | Whether Concentriq AP, Dx, LS, or another deployment model fits the lab setting. | 6 official sources |
| Aiforia | Labs evaluating AI-supported pathology workflows across breast, prostate, lung, colorectal, gastric, or lymph node use cases. | Which Aiforia clinical suite and AI models match the tissue, stain, and diagnostic workflow. | 6 official sources |
| Mindpeak | Labs evaluating AI-assisted IHC scoring, biomarker quantification, and interoperable pathology AI across routine diagnostic or pharma workflows. | Which Mindpeak suite or module is in scope: breast IHC, PD-L1, HER2, prostate, onychomycosis, lymphocyte quantification, peakDissect, or a biopharma workflow. | 4 official sources |
| Aignostics | Research and biopharma teams that need quantitative H&E tumor microenvironment features, validation documentation, and controlled data-handling terms. | Research-use-only status and whether any workflow is explicitly excluded from diagnostic procedures. | 3 official sources |
| Lumea | Specialty pathology groups that want one operational layer for digital diagnosis, AI partner access, molecular testing, and lab workflow standardization. | Which Lumea component is in scope: Viewer+, BxLink, tissue-handling tools, specialty workflow, AI marketplace, or molecular ordering. | 5 official sources |
| Visiopharm | Labs and research teams evaluating AI-assisted biomarker scoring, tissue quantification, companion-diagnostic support, and interoperable pathology image analysis. | Which Visiopharm platform or APP is in scope: diagnostic decision support, Discovery, Phenoplex, Qualitopix, or a partner integration. | 5 official sources |
| Tribun Health | Labs that need a web-based image-management layer with scanner/LIS interoperability, remote collaboration, and access to AI modules in digital pathology workflows. | Which module is being purchased: CaloPix, CaloPix Archive, AI Apps, TeleSlide, MacroCam, or a partner integration. | 4 official sources |
| Roche navify Digital Pathology | Labs standardizing Roche-compatible digital pathology workflows that need scanner interoperability, LIS/PACS integration, cloud or on-prem options, and governed access to image-analysis algorithms. | Which deployment is in scope: cloud navify Digital Pathology, on-prem software, Roche Digital Pathology Dx, scanners, navify Pathology Lab Hub, analytics, or algorithm access. | 6 official sources |
| PathPresenter | Pathology groups that need a vendor-agnostic IMS foundation with clinical viewing, remote collaboration, LIS/scanner interoperability, and a governed way to evaluate pathology AI models. | Whether the purchase covers Clinical Viewer, ConsultConnect, education, biorepository management, AI integrations, or a combination of modules. | 8 official sources |
| DoMore Diagnostics Histotype Px Colorectal | Oncology and pathology teams exploring AI-supported colorectal cancer risk stratification where results are reviewed alongside TNM staging, ctDNA, guidelines, and clinician judgment. | Whether Histotype Px Colorectal is cleared or CE-marked for the intended country, cancer stage, specimen, scanner, and diagnostic or research workflow. | 4 official sources |
| PreciseDx PreciseBreast | Breast cancer programs evaluating whether routine H&E pathology can add AI-supported recurrence-risk information alongside pathology, genomic assays, guidelines, and tumor-board review. | Whether PreciseBreast is available and authorized for the intended country, specimen type, breast cancer subtype, stage, and diagnostic or research workflow. | 5 official sources |
| Lunit SCOPE | Teams evaluating AI pathology analysis for oncology biomarker programs, immunotherapy research, trial enrichment, or governed pathology AI pilots with module-specific intended-use review. | Which module is in scope: SCOPE IO, IHC Suite, uIHC, HER2, PD-L1, GP, or another Lunit precision-oncology product. | 6 official sources |
Jump to this category on the comparison page
Digital pathology AI applications for cancer pathology, including Paige Prostate.
AI-enabled digital pathology platform with image management and algorithm access.
FDA-cleared digital cytology system combining volumetric imaging, Genius Cervical AI, image management, and cytologist or pathologist review.
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.
CE-marked and Korea MFDS-approved prostate pathology AI that analyzes digitized H&E slides for cancer detection and Gleason-pattern support under pathologist review.
Concentriq digital pathology platform that supports diagnostic, research, and AI-enabled pathology workflows.
AI pathology platform with clinical suites for whole-slide image workflows, quantitative overlays, and pathologist review.
Digital pathology AI company offering diagnostic suites and biomarker-analysis tools for tissue image workflows.
Digital pathology AI company whose Atlas H&E-TME product analyzes whole-slide images for tumor microenvironment profiling in research workflows.
Digital pathology platform connecting specimen workflow, whole-slide viewing, case management, AI integrations, and specialty diagnostic workflows.
Precision pathology software company offering AI image-analysis workflows, IVDR-certified diagnostic APPs, research tools, and integration paths with pathology platforms.
Digital pathology platform centered on CaloPix for whole-slide image management, visualization, analysis, AI apps, telepathology, and lab integration.
Enterprise digital pathology software from Roche for pathology case workflow, image management, collaboration, integration, and access to AI-based image analysis algorithms.
Enterprise digital pathology image-management system with a cleared clinical viewer and workflow modules for clinical care, consultations, research, education, and AI model access.
Digital pathology biomarker that analyzes colorectal cancer histology slides to support recurrence and survival risk stratification for adjuvant-treatment review.
AI-powered breast cancer prognostic test that combines histology-derived features with clinical factors to help stratify recurrence risk for clinician review.
Digital pathology AI suite from Lunit for precision-oncology research, biomarker discovery, IHC analysis, and selected pathologist-assistive workflows.
16 products
Clinical evidence and questions
Medium to high risk
20 products
Clinical documentation and scribes
Lower to medium risk
69 products
Medical imaging and radiology
High risk
15 products
Surgery and procedural intelligence
High risk
40 products
Clinical operations and revenue cycle
Medium risk
25 products
Patient access, triage, and agents
Medium to high risk